Katie Stuart

Katie Stuart

Executive Director & Head of Commercial TP-CP USA

Business Development
About

Katie Stuart brings 27 years of experience in the pharmaceutical industry, with a background spanning analytical chemistry and business development. Prior to joining Quotient Sciences, she held roles at EAG Labs, Azopharma, and ALZA/Johnson & Johnson. Katie holds a B.S. in Genetics from UC Davis and Associate of Science degrees in Liberal Arts, General Science, and Chemistry.

Quotient Sciences Translational Pharmaceutics
Translational Pharmaceutics, Drug Product Optimization, First-in-Human, Human ADME

Translational Pharmaceutics® Integrated Drug Development Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Read More